Cargando…

Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.

Multidrug resistance phenotypes in human tumours are associated with the overexpression of the 170 kDa P-glycoprotein encoded by the multidrug resistance 1 (MDR1) gene, and also with that of the non-P-glycoprotein-mediated multidrug resistance gene, MRP, which encodes a 190 kDa membrane ATP-binding...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, T., Koike, K., Ohga, T., Kubo, T., Wada, M., Kohno, K., Mori, T., Hidaka, K., Kuwano, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033970/
https://www.ncbi.nlm.nih.gov/pubmed/7640227
_version_ 1782136954127646720
author Abe, T.
Koike, K.
Ohga, T.
Kubo, T.
Wada, M.
Kohno, K.
Mori, T.
Hidaka, K.
Kuwano, M.
author_facet Abe, T.
Koike, K.
Ohga, T.
Kubo, T.
Wada, M.
Kohno, K.
Mori, T.
Hidaka, K.
Kuwano, M.
author_sort Abe, T.
collection PubMed
description Multidrug resistance phenotypes in human tumours are associated with the overexpression of the 170 kDa P-glycoprotein encoded by the multidrug resistance 1 (MDR1) gene, and also with that of the non-P-glycoprotein-mediated multidrug resistance gene, MRP, which encodes a 190 kDa membrane ATP-binding protein. We have previously reported that overexpression of MRP appears to be responsible for spontaneous multidrug resistance in some human glioma cell lines (Abe et al., Int. J. Cancer, 58, 860-864, 1994). In this study, we investigated whether chemosensitising agents of P-glycoprotein-mediated multidrug resistance such as verapamil, a biscoclaurine alkaloid (cepharanthine), and a dihydropyridine analogue (NIK250) could also reverse multidrug resistance in human glioma cells. The glioma cell lines were the two MRP-expressing cell lines, T98G and IN500, an MDR1-expressing cell line, CCF-STTG1, and the MRP1 MDR1-non-expressing cell line, IN157. Verapamil and NIK250 almost completely reversed drug resistance to vincristine, etoposide and doxorubicin in T98G cells, while they also reversed drug resistance to vincristine and etoposide, but only partially to doxorubicin in IN500 cells. Cepharanthine as well as verapamil and NIK250 reversed vincristine resistance in CCF-STTG1 cells, but cepharanthine only partially reversed drug resistance in T98G and IN500 cells. The cellular accumulation of [3H]etoposide increased about 2- and 3-fold compared with control in T98G cells in the presence of verapamil and NIK250 respectively. Furthermore, the release of doxorubicin from the nuclei of T98G cells was blocked by NIK250. However, NIK250 and verapamil caused no apparent increase in vincristine accumulation in T98G cells. NIK250 or verapamil might exert inhibitory effects upon MRP function, resulting in a reversal of MRP-mediated spontaneous multidrug resistance in cultured human glioma cells. IMAGES:
format Text
id pubmed-2033970
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20339702009-09-10 Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1. Abe, T. Koike, K. Ohga, T. Kubo, T. Wada, M. Kohno, K. Mori, T. Hidaka, K. Kuwano, M. Br J Cancer Research Article Multidrug resistance phenotypes in human tumours are associated with the overexpression of the 170 kDa P-glycoprotein encoded by the multidrug resistance 1 (MDR1) gene, and also with that of the non-P-glycoprotein-mediated multidrug resistance gene, MRP, which encodes a 190 kDa membrane ATP-binding protein. We have previously reported that overexpression of MRP appears to be responsible for spontaneous multidrug resistance in some human glioma cell lines (Abe et al., Int. J. Cancer, 58, 860-864, 1994). In this study, we investigated whether chemosensitising agents of P-glycoprotein-mediated multidrug resistance such as verapamil, a biscoclaurine alkaloid (cepharanthine), and a dihydropyridine analogue (NIK250) could also reverse multidrug resistance in human glioma cells. The glioma cell lines were the two MRP-expressing cell lines, T98G and IN500, an MDR1-expressing cell line, CCF-STTG1, and the MRP1 MDR1-non-expressing cell line, IN157. Verapamil and NIK250 almost completely reversed drug resistance to vincristine, etoposide and doxorubicin in T98G cells, while they also reversed drug resistance to vincristine and etoposide, but only partially to doxorubicin in IN500 cells. Cepharanthine as well as verapamil and NIK250 reversed vincristine resistance in CCF-STTG1 cells, but cepharanthine only partially reversed drug resistance in T98G and IN500 cells. The cellular accumulation of [3H]etoposide increased about 2- and 3-fold compared with control in T98G cells in the presence of verapamil and NIK250 respectively. Furthermore, the release of doxorubicin from the nuclei of T98G cells was blocked by NIK250. However, NIK250 and verapamil caused no apparent increase in vincristine accumulation in T98G cells. NIK250 or verapamil might exert inhibitory effects upon MRP function, resulting in a reversal of MRP-mediated spontaneous multidrug resistance in cultured human glioma cells. IMAGES: Nature Publishing Group 1995-08 /pmc/articles/PMC2033970/ /pubmed/7640227 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Abe, T.
Koike, K.
Ohga, T.
Kubo, T.
Wada, M.
Kohno, K.
Mori, T.
Hidaka, K.
Kuwano, M.
Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
title Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
title_full Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
title_fullStr Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
title_full_unstemmed Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
title_short Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
title_sort chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing mrp or mdr1.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033970/
https://www.ncbi.nlm.nih.gov/pubmed/7640227
work_keys_str_mv AT abet chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT koikek chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT ohgat chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT kubot chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT wadam chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT kohnok chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT morit chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT hidakak chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1
AT kuwanom chemosensitisationofspontaneousmultidrugresistancebya14dihydropyridineanalogueandverapamilinhumangliomacelllinesoverexpressingmrpormdr1